Your browser doesn't support javascript.
loading
Pathogenic Activation of Mesenchymal Stem Cells Is Induced by the Disease Microenvironment in Systemic Sclerosis.
Taki, Zeinab; Gostjeva, Elena; Thilly, William; Yaseen, Bodoor; Lopez, Henry; Mirza, Maria; Hassuji, Zainab; Vigneswaran, Shivanee; Ahmed Abdi, Bahja; Hart, Amy; Arumalla, Nikita; Thomas, Gemma; Denton, Christopher P; Suleman, Yasir; Liu, Huan; Venturini, Cristina; O'Reilly, Steven; Xu, Shiwen; Stratton, Richard.
Afiliación
  • Taki Z; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Gostjeva E; Massachusetts Institute of Technology, Cambridge.
  • Thilly W; Massachusetts Institute of Technology, Cambridge.
  • Yaseen B; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Lopez H; MuriGenics, Inc., Vallejo, California, and Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Mirza M; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Hassuji Z; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Vigneswaran S; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Ahmed Abdi B; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Hart A; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Arumalla N; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Thomas G; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Denton CP; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Suleman Y; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Liu H; School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, China, and Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Venturini C; University College London, London, UK.
  • O'Reilly S; Northumbria University, Newcastle upon Tyne, UK.
  • Xu S; Royal Free Hospital Campus and University College London Medical School, London, UK.
  • Stratton R; Royal Free Hospital Campus and University College London Medical School, London, UK.
Arthritis Rheumatol ; 72(8): 1361-1374, 2020 08.
Article en En | MEDLINE | ID: mdl-32237059
OBJECTIVE: In systemic sclerosis (SSc), a persistent tissue repair process leads to progressive fibrosis of the skin and internal organs. The role of mesenchymal stem cells (MSCs), which characteristically initiate and regulate tissue repair, has not been fully evaluated. We undertook this study to investigate whether dividing metakaryotic MSCs are present in SSc skin and to examine whether exposure to the disease microenvironment activates MSCs and leads to transdifferentiation. METHODS: Skin biopsy material from patients with recent-onset diffuse SSc was examined by collagenase spread of 1-mm-thick surface-parallel sections, in order to identify dividing metakaryotic stem cells in each tissue plane. Adipose-derived MSCs from healthy controls were treated with dermal blister fluid (BF) from patients with diffuse SSc and profiled by next-generation sequencing, or they were evaluated for phenotypic changes relevant to SSc. Differential responses of dermal fibroblasts were studied in parallel. RESULTS: MSC-like cells undergoing active metakaryotic division were identified in SSc sections (but not control sections) most prominently in the deep dermis and adjacent to damaged microvessels, in both clinically involved and uninvolved skin. Furthermore, exposure to SSc BF caused selective MSC activation, inducing a myofibroblast signature, while reducing signatures of vascular repair and adipogenesis and enhancing migration and contractility. Microenvironmental factors implicated in inducing transdifferentiation included the profibrotic transforming growth factor ß, the presence of lactate, and mechanosensing, while the microenvironment Th2 cytokine, interleukin-31, enhanced osteogenic commitment (calcinosis). CONCLUSION: Dividing MSC-like cells are present in the SSc disease microenvironment where multiple factors, likely acting in concert, promote transdifferentiation and lead to a complex and resistant disease state.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Esclerodermia Difusa / Transdiferenciación Celular / Células Madre Mesenquimatosas / Microambiente Celular Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Arthritis Rheumatol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Esclerodermia Difusa / Transdiferenciación Celular / Células Madre Mesenquimatosas / Microambiente Celular Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Arthritis Rheumatol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos